0001179110-17-013677.txt : 20171102 0001179110-17-013677.hdr.sgml : 20171102 20171102185229 ACCESSION NUMBER: 0001179110-17-013677 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171031 FILED AS OF DATE: 20171102 DATE AS OF CHANGE: 20171102 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gull Global Ltd CENTRAL INDEX KEY: 0001636301 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35024 FILM NUMBER: 171174124 BUSINESS ADDRESS: STREET 1: PO BOX N-4899, 2/F BAHAMAS FINANCIAL CTR STREET 2: SHIRLEY & CHARLOTTE STREETS CITY: NASSAU STATE: C5 ZIP: BH1-1000 BUSINESS PHONE: 8019547100 MAIL ADDRESS: STREET 1: PO BOX N-4899, 2/F BAHAMAS FINANCIAL CTR STREET 2: SHIRLEY & CHARLOTTE STREETS CITY: NASSAU STATE: C5 ZIP: BH1-1000 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: USANA HEALTH SCIENCES INC CENTRAL INDEX KEY: 0000896264 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 870500306 STATE OF INCORPORATION: UT FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3838 WEST PARKWAY BLVD. CITY: SALT LAKE CITY STATE: UT ZIP: 84120-6336 BUSINESS PHONE: 8019547100 MAIL ADDRESS: STREET 1: 3838 WEST PARKWAY BLVD. STREET 2: 3838 WEST PARKWAY BLVD. CITY: SALT LAKE CITY STATE: UT ZIP: 84120-6336 FORMER COMPANY: FORMER CONFORMED NAME: USANA INC DATE OF NAME CHANGE: 19930125 4 1 edgar.xml FORM 4 - X0306 4 2017-10-31 0 0000896264 USANA HEALTH SCIENCES INC USNA 0001636301 Gull Global Ltd PO BOX N-4899, 2/F BAHAMAS FINANCIAL CTR SHIRLEY & CHARLOTTE STREETS NASSAU C5 BH1-1000 BAHAMAS 0 0 1 0 Common Stock 2017-10-31 4 S 0 3292 66.0091 D 12053403 D Common Stock 2017-11-01 4 S 0 17107 65.4162 D 12036296 D Common Stock 2017-11-02 4 S 0 22893 65.0245 D 12013403 D The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Weighted average price. Price range in multiple transactions was $66.00 to $66.10, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 14, 2017. Weighted average price. Price range in multiple transactions was $64.85 to $65.85, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. Weighted average price. Price range in multiple transactions was $64.40 to $65.40, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. James Bramble, as attorney in fact. 2017-11-02